91 related articles for article (PubMed ID: 26091065)
1. Leukemia-Associated Mutations in Nucleophosmin Alter Recognition by CRM1: Molecular Basis of Aberrant Transport.
Arregi I; Falces J; Olazabal-Herrero A; Alonso-Mariño M; Taneva SG; Rodríguez JA; Urbaneja MA; Bañuelos S
PLoS One; 2015; 10(6):e0130610. PubMed ID: 26091065
[TBL] [Abstract][Full Text] [Related]
2. Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells.
Etchin J; Sun Q; Kentsis A; Farmer A; Zhang ZC; Sanda T; Mansour MR; Barcelo C; McCauley D; Kauffman M; Shacham S; Christie AL; Kung AL; Rodig SJ; Chook YM; Look AT
Leukemia; 2013 Jan; 27(1):66-74. PubMed ID: 22847027
[TBL] [Abstract][Full Text] [Related]
3. Nuclear export of BATF2 enhances colorectal cancer proliferation through binding to CRM1.
Zhou J; Lei Z; Chen J; Liao S; Chen Y; Liu C; Huang S; Li L; Zhang Y; Wang P; Huang Y; Li J; Liang H
Clin Transl Med; 2023 May; 13(5):e1260. PubMed ID: 37151195
[TBL] [Abstract][Full Text] [Related]
4. Nucleophosmin interacts with FOXM1 and modulates the level and localization of FOXM1 in human cancer cells.
Bhat UG; Jagadeeswaran R; Halasi M; Gartel AL
J Biol Chem; 2011 Dec; 286(48):41425-41433. PubMed ID: 21979956
[TBL] [Abstract][Full Text] [Related]
5. Exportin-mediated nucleocytoplasmic transport maintains Pch2 homeostasis during meiosis.
Herruzo E; Sánchez-Díaz E; González-Arranz S; Santos B; Carballo JA; San-Segundo PA
PLoS Genet; 2023 Nov; 19(11):e1011026. PubMed ID: 37948444
[TBL] [Abstract][Full Text] [Related]
6. The acidic stretch and the C-terminal nuclear export signal motif of NPM1 mutant: are they druggable in AML?
Falini B; Gjertsen BT; Andresen V
Leukemia; 2023 Nov; 37(11):2173-2175. PubMed ID: 37740103
[No Abstract] [Full Text] [Related]
7. X-ray-downregulated nucleophosmin induces abnormal polarization by anchoring to G-actin.
Dai Y; Yu Y; Nie J; Gu K; Pei H
Life Sci Space Res (Amst); 2024 Feb; 40():81-88. PubMed ID: 38245352
[TBL] [Abstract][Full Text] [Related]
8. Missense mutations in Myc Box I influence MYC cellular localization, mRNA partitioning and turnover to promote leukemogenesis.
Arthur NB; Christensen KA; Mannino K; Ruzinova MB; Kumar A; Gruszczynska A; Day RB; Erdmann-Gilmore P; Mi Y; Sprung R; York CR; Reid Townsend R; Spencer DH; Sykes SM; Ferraro F
bioRxiv; 2023 Oct; ():. PubMed ID: 37961226
[TBL] [Abstract][Full Text] [Related]
9. Keratin-17 Promotes p27KIP1 Nuclear Export and Degradation and Offers Potential Prognostic Utility.
Escobar-Hoyos LF; Shah R; Roa-Peña L; Vanner EA; Najafian N; Banach A; Nielsen E; Al-Khalil R; Akalin A; Talmage D; Shroyer KR
Cancer Res; 2015 Sep; 75(17):3650-62. PubMed ID: 26109559
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic nucleophosmin has elevated T199 phosphorylation upon which G2/M phase progression is dependent.
Chan N; Lim TM
Sci Rep; 2015 Jun; 5():11777. PubMed ID: 26123729
[TBL] [Abstract][Full Text] [Related]
11. Three cardiovirus Leader proteins equivalently inhibit four different nucleocytoplasmic trafficking pathways.
Ciomperlik JJ; Basta HA; Palmenberg AC
Virology; 2015 Oct; 484():194-202. PubMed ID: 26115166
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy in acute myeloid leukemia.
Grosso DA; Hess RC; Weiss MA
Cancer; 2015 Aug; 121(16):2689-704. PubMed ID: 26095886
[TBL] [Abstract][Full Text] [Related]
13. Conformational Rearrangements Regulating the DNA Repair Protein APE1.
Komaniecka N; Porras M; Cairn L; Santas JA; Ferreiro N; Penedo JC; Bañuelos S
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887361
[TBL] [Abstract][Full Text] [Related]
14. Significance of NPM1 Gene Mutations in AML.
Hindley A; Catherwood MA; McMullin MF; Mills KI
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576201
[TBL] [Abstract][Full Text] [Related]
15. NPM1 Mutational Status Underlines Different Biological Features in Pediatric AML.
Tregnago C; Benetton M; Padrin D; Polato K; Borella G; Da Ros A; Marchetti A; Porcù E; Del Bufalo F; Mecucci C; Locatelli F; Pigazzi M
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298672
[TBL] [Abstract][Full Text] [Related]
16. Conformational stabilization as a strategy to prevent nucleophosmin mislocalization in leukemia.
Urbaneja MA; Skjærven L; Aubi O; Underhaug J; López DJ; Arregi I; Alonso-Mariño M; Cuevas A; Rodríguez JA; Martinez A; Bañuelos S
Sci Rep; 2017 Oct; 7(1):13959. PubMed ID: 29066752
[TBL] [Abstract][Full Text] [Related]
17. Destabilisation, aggregation, toxicity and cytosolic mislocalisation of nucleophosmin regions associated with acute myeloid leukemia.
Scognamiglio PL; Di Natale C; Leone M; Cascella R; Cecchi C; Lirussi L; Antoniali G; Riccardi D; Morelli G; Tell G; Chiti F; Marasco D
Oncotarget; 2016 Sep; 7(37):59129-59143. PubMed ID: 27494862
[TBL] [Abstract][Full Text] [Related]
18. A cellular reporter to evaluate CRM1 nuclear export activity: functional analysis of the cancer-related mutant E571K.
García-Santisteban I; Arregi I; Alonso-Mariño M; Urbaneja MA; Garcia-Vallejo JJ; Bañuelos S; Rodríguez JA
Cell Mol Life Sci; 2016 Dec; 73(24):4685-4699. PubMed ID: 27312238
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
